Frost & Sullivan
Dorman Followwill’s inspirational leadership and contributions to the global Frost & Sullivan team have accounted for outstanding performance in regional EIA sales and profit as a Partner, Director and Executive Committee member for the Europe, Israel, and Africa region, in 2008 and 2009, as well as record profitability in the Healthcare business unit in North America from 2002-2005. Dorman has played a leading role in some of the largest consulting engagements in the history of the firm, including ongoing projects with Bayer Biologicals and Philips, and key projects with Merck Chemicals, Montagu Private Equity, and Novartis. He also supports several key sales and new business development initiatives in EIA. Dorman has a B.A. in The Management of Organisations from Stanford University and currently resides in Oxford, U.K., with his family.